Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of substituted 2, 3-dihydroimidazo[1,2-c]quinazolines for the treatment of myeloma

Use of substituted 2, 3-dihydroimidazo[1,2-c]quinazolines for the treatment of myeloma

US Patent 10383877 · Granted Aug 20, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combinations of copanlisib with anti-PD-1 antibody2023
Substituted 2,3-dihydroimidazo[1,2-C]quinazoline-containing combinations2019
Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines for treating lymphomas2019
Use of substituted 2,3-dihydroimidazo[1,2-C]quinazolines2019
Compounds2018
Combination of PI3K-inhibitors2018
Combination of PI3K-inhibitors2018
Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for treating lymphomas2018
Aminoalcohol substituted 2,3-dihydroimidazo[1,2-C]quinazoline derivatives useful2018
Amido-substituted azole compounds2018
Alkoxy-substituted 2,3-dihydroimidazo[1,2-C]quinazolines2017
Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-C]quinolines2017